Patent details

LUC00103 Product Name: Duzallo - allopurinol/lésinurad ou un/des sel(s) pharmaceutiquement acceptable(s) de celui-ci

Basic Information

Publication number:
LUC00103
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP088539002
Legal Status:
Invalid
Application number:
LUC00103
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1300
Marketing Authorization Type:
Marketing Authorization Date:
27/08/2018
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
18/02/2019
First Marketing Authorization date:
27/08/2018
Grant date:
27/12/2019
Activation date:
Publication date:
19/02/2019
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
27/08/2033
SPC Extension Expiration:
27/08/2033
Rejection date:
Withdrawal date:

Owner

From:
18/02/2019
 
 

Name:
Ardea Biosciences, Inc.
Address:
9390 Towne Centre Drive, San Diego CA 92121, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
18/02/2019
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2019/04
Publication date:
11/03/2019
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2020/01
Publication date:
13/01/2020
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
19/02/2019 Outgoing Correspondence 1
27/12/2019 Publication 1
18/02/2019 General Document 22
18/02/2019 Incoming Correspondence (Post) 1
18/02/2019 General Document 49
27/12/2019 Certificate 1
19/02/2019 Publication 1
18/02/2019 Application Form 4
18/02/2019 General Document 2
27/12/2019 Outgoing Correspondence 1
18/02/2019 General Document 2
18/02/2019 General Document 4
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56